Reported 2 days ago
iRhythm Technologies (IRTC) has established a commanding presence in the cardiac monitoring sector, claiming a 70% market share with its Zio Monitor, which disrupts traditional Holter monitors. Recently, Freedom Capital Markets initiated coverage on IRTC with a Buy rating and a $205 price target, highlighting the company’s robust growth in the primary care market and positive sales trends. The firm expects an increase in market share with the upcoming launch of a 21-day monitoring device.
Source: YAHOO